FDA emails about Apple Watch • MuckRock

5 Communications
6 Files

Communications

From: Aarian Marshall

09/12/2018

Subject: Freedom of Information Act Request: FDA emails about Apple Watch

Portal

To Whom It May Concern:

Pursuant to the Freedom of Information Act, I hereby request the following records:

Any emails, written communications, documents, or other communications between FCC officials and representatives from Apple, which contain the words “EKG,” “ECG,” "Apple Watch, or “electrocardiography."

The search for responsive records should include individuals and locations where records are likely to exist, including but not limited, to the Offices of Commissioner Dr. Scott Gottlieb, the Office of Media Affairs, and the Offices of the Chief Counsel. The FCC should limit its search to responsive records created between January 1, 2015 to September 12, 2018.

WIRED seeks all responsive records regardless of format, medium, or physical characteristics. In conducting your search, please understand the terms “records,” “communications,” and “documents” in their broadest sense, to include any written, typed, recorded, graphic, printed, or audio material of any kind.

We seek records of any kind, including electronic records, audiotapes, videotapes, and photographs, as well as letters, emails,facsimiles, telephone messages, voice mail messages and transcripts, notes, or minutes of any meetings,telephone conversations or discussions.

Our request includes any attachments to these records. No category of material should be omitted from search, collection, and production. You may not exclude searches of files or emails in the personal custody of your officials, such as personal email accounts. Records of official business conducted using unofficial systems or stored outside of official files is subject to the Federal Records Act and FOIA.

In the event some portions of the requested records are properly exempt from disclosure, please disclose any reasonably segregable nonexempt portions of the requested records. If it is your position that a document contains non-exempt segments, but that those non-exempt segments are so dispersed throughout the document as to make segregation impossible, please state what portion of the document is non-exempt, and how the material is dispersed throughout the document. Claims of non-segregability must be made with the 20
same degree of detail as required for claims of exemptions in a Vaughn index. If a request is denied in whole, please state specifically that it is not reasonable to segregate portions of the record for release.

The requested documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.

Sincerely,

Louise Matsakis

From: Food and Drug Administration

09/13/2018

Subject: FOI Request Received

Portal

*** This is an automated message. Please do not reply to this email. ***

Reference: FDA1846686
Dear Requester,
This is to confirm that you submitted a request for record(s) from the Food and Drug Administrationpursuant to the Freedom of Information Act.
FOIA staff will review your request to determine whether it has sufficient information to be processed;if so, you will receive another email as a formal acknowledgement of your request, with a control number for your request. If your request is not sufficiently described,or if there are any other deficiencies with your submission, FOIA staff will contact you via telephone or email.

From: Food and Drug Administration

09/18/2018

Subject: FDA Receipt of FOI Request

Portal

Note: Do NOT reply directly to this E-mail
MUCKROCK Louise Matsakis
Re: Confirmation # FDA1846686
In Reply refer to: 2018-7444
The Food and Drug Administration (FDA) has received your Freedom of Information Act (FOIA) request for records regarding:
COMMUNICATIONS BETWEEN FCC AND APPLE
Original Subject: Any emails, written communications, documents, or other communications between FCC officials and representatives from Apple?, which contain the words ?EKG,? ?ECG,? "Apple Watch, or ?electrocardiography." SEE ATTACHED REQUEST LETTER FOR FURTHER DESCRIPTION
We will respond as soon as possible and may charge you a fee for processing your request. If your informational needs change, and you no longer need the requested records, please contact us to cancel your request, as charges may be incurred once processing of your request has begun. For more information on processing fees, please see
http://www.fda.gov/RegulatoryInformation/FOI/FOIAFees/default.htm. If you have any questions about your request, please call Sarah B. Kotler, Director, Division Of Freedom Of Information at (301) 796-8976 or write to us at: (http://www.fda.gov/RegulatoryInformation/FOI/FOIAFees/default.htm)
Division of Freedom of Information, U.S. Food and Drug Administration
5630 Fishers Lane, Room 1035
Rockville, MD 20857
Fax:(301)827-9267
You also have the right to seek dispute resolution services from:
FDA FOIA Public Liaison
Office of the Executive Secretariat
5630 Fishers Lane, Room 1050
Rockville, MD 20857
E-Mail: FDAFOIA@fda.hhs.gov and/or:
Office of Government Information Services
National Archives and Administration
8601 Adelphi Road ? OGIS
College Park, MD 20740-6001
Telephone: 202-741-5770
Toll-Free: 1-877-684-6448
E-mail: ogis@nara.gov
Fax: 202-741-5769

From: Food and Drug Administration

09/18/2018

Subject: FDA FOIA 2018-7444

Portal

Dear Requester,

We received your request for:

Any emails, written communications, documents, or other communications between FCC officials and representatives from Apple, which contain the words "EKG," "ECG," "Apple Watch, or "electrocardiography.

You submitted this request to FDA. Please submit your request to the FCC. Information regarding FCC FOIA is at:

https://www.fcc.gov/general/foia-0

Please contact me directly if you have any questions at 301-796-8976 or Sarah.Kotler@fda.hhs.gov. You may also contact the FDA FOIA Public Liaison, Office of the Executive Secretariat, 5630 Fishers Lane, Room 1050, Rockville, MD 20857; email: FDAFOIA@fda.hhs.gov<mailto:FDAFOIA@fda.hhs.gov>.

Sincerely,

Sarah B. Kotler, J.D.
Director
Office of the Executive Secretariat
Division of Freedom of Information
U.S. Food and Drug Administration
Tel: 301-796-8976
Sarah.Kotler@fda.hhs.gov<mailto:Sarah.Kotler@fda.hhs.gov>

[cid:image001.png@01D1C57E.DFA022A0]<http://www.fda.gov/>

[cid:image002.jpg@01D1C57E.DFA022A0]<https://www.facebook.com/FDA> [cid:image003.jpg@01D1C57E.DFA022A0] <https://twitter.com/US_FDA> [cid:image004.jpg@01D1C57E.DFA022A0] <http://www.youtube.com/user/USFoodandDrugAdmin> [cid:image005.jpg@01D1C57E.DFA022A0] <http://www.flickr.com/photos/fdaphotos/> [cid:image006.jpg@01D1C57E.DFA022A0] <http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/default.htm>